Moreover, ERα activation has been implicated in enhancing the invasiveness of prostate cancer cells, implying its potential contribution to tumor cell motility through the epithelial–mesenchymal transition (EMT) process [33,34,35]. This evidence concerns the gene ESR1 and prostate carcinoma.